You are here

Herbert Smith Freehills advises arrangers on acquisition financing for GlaxoSmithKline

28 March 2018 | London
Deals and cases

Share

HSF London's finance team has advised the mandated lead arrangers on their successful acquisition financing for GlaxoSmithKline's $13 billion buyout of Novartis' 36.5% stake in their consumer healthcare joint venture.

The team involved in negotiating the financing was led by partner Will Nevin with the assistance of senior associate Elliot Beard and key associates Oliver Henderson and Ben Robinson.

Will Nevin commented: "This deal is one of the largest in the London market to date this year and shows the continued strength and development of our bank-facing acquisition finance practice".

About Herbert Smith Freehills

Operating from 27 offices across Asia Pacific, EMEA and North America, Herbert Smith Freehills is at the heart of the new global business landscape providing premium quality, full-service legal advice. The firm provides many of the world’s most important organisations with access to market-leading dispute resolution, projects and transactional legal advice, combined with expertise in a number of global industry sectors, including Banks, Consumer products, Energy, Financial buyers, Infrastructure & Transport, Mining, Pharmaceuticals & Healthcare, Real estate, TMT and Manufacturing & Industrials.

www.herbertsmithfreehills.com

Follow us on Twitter  @HSFPressOffice  

Media Contact

For further information on this news article, please contact:

Carl Philip Brandgard, Communications Manager

London
Tel: 
+44 20 7466 3244